Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and safety of once-daily extended-release metformin at breakfast vs dinner in type 2 diabetes
2011-006054-82Phase 2Completed
- Sponsor
- Servier
- Start
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of metformin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Servier. Primary endpoint: HbA1c. Started Apr 2012; status: completed.
02
Drugs
metformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2011-006054-82.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-006054-82.